Abstract
Tremor is a common complaint for many patients. Caffeine and β-adrenergic agonists are well-recognised drugs that cause or exacerbate tremors. Other tremorogenic drugs, such as selective serotonin reuptake inhibitors and tricyclic antidepressants, are less well recognised. Recognition of the drugs that can cause or exacerbate tremors can help prompt diagnosis, avoids unnecessary tests, and allows clinicians to quickly take corrective action (usually by discontinuing the tremor-inducing drugs). The aim of this review is to provide clinicians with current information on drugs that are associated with tremor and the correct treatment of these drug-induced tremors.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 866-876 |
| Number of pages | 11 |
| Journal | Lancet Neurology |
| Volume | 4 |
| Issue number | 12 |
| DOIs | |
| State | Published - Dec 1 2005 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Drug-induced tremors. / Morgan, John Christopher; Sethi, Kapil D.
In: Lancet Neurology, Vol. 4, No. 12, 01.12.2005, p. 866-876.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Drug-induced tremors
AU - Morgan, John Christopher
AU - Sethi, Kapil D.
PY - 2005/12/1
Y1 - 2005/12/1
N2 - Tremor is a common complaint for many patients. Caffeine and β-adrenergic agonists are well-recognised drugs that cause or exacerbate tremors. Other tremorogenic drugs, such as selective serotonin reuptake inhibitors and tricyclic antidepressants, are less well recognised. Recognition of the drugs that can cause or exacerbate tremors can help prompt diagnosis, avoids unnecessary tests, and allows clinicians to quickly take corrective action (usually by discontinuing the tremor-inducing drugs). The aim of this review is to provide clinicians with current information on drugs that are associated with tremor and the correct treatment of these drug-induced tremors.
AB - Tremor is a common complaint for many patients. Caffeine and β-adrenergic agonists are well-recognised drugs that cause or exacerbate tremors. Other tremorogenic drugs, such as selective serotonin reuptake inhibitors and tricyclic antidepressants, are less well recognised. Recognition of the drugs that can cause or exacerbate tremors can help prompt diagnosis, avoids unnecessary tests, and allows clinicians to quickly take corrective action (usually by discontinuing the tremor-inducing drugs). The aim of this review is to provide clinicians with current information on drugs that are associated with tremor and the correct treatment of these drug-induced tremors.
UR - http://www.scopus.com/inward/record.url?scp=27744571746&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27744571746&partnerID=8YFLogxK
U2 - 10.1016/S1474-4422(05)70250-7
DO - 10.1016/S1474-4422(05)70250-7
M3 - Review article
C2 - 16297844
AN - SCOPUS:27744571746
VL - 4
SP - 866
EP - 876
JO - The Lancet Neurology
JF - The Lancet Neurology
SN - 1474-4422
IS - 12
ER -